NVAX - 2 High-Growth Stocks I'm Buying Right Now
The market may have caught a cold this week, but that doesn't mean that there aren't a number of attractive buying opportunities. Personally, I'm always on the hunt for a good bargain. So I view this historically ugly pullback basically as nothing more than a chance to buy some of my favorite names. Small-cap growth stocks -- especially those in the biotech space -- have my eye in particular this week.
Which names should risk-tolerant investors check out? My two favorite picks in the small-cap biotech arena right now are Bicycle Therapeutics (NASDAQ: BCYC) and Novavax (NASDAQ: NVAX). Both of these pre-revenue biotech stocks are uber-risky, but they also offer investors a reasonable shot at exponential returns on capital within an exceedingly short period of time. Here's a brief overview of each company.
Image source: Getty Images.